White matter tauopathy with globular glial inclusions: A distinct sporadic frontotemporal lobar segeneration

Journal of Neuropathology and Experimental Neurology

Volumn 67, Issue 10, 2008, Pages 963-975

  Kovacs, Gabor G ^a,b,c   Majtenyi, Katalin ^b   Spina, Salvatore ^c,d   Murrell, Jill R ^c   Gelpi, Ellen ^a   Hoftberger, Romana ^a   Fraser, Graham ^e   Crowther, R Anthony ^e   Goedert, Michel ^e   Budka, Herbert ^a   Ghetti, Bernardino ^c  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b NATIONAL INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Hungary)

^c INDIANA UNIVERSITY   (United States)

^d UNIVERSITY OF SIENA   (Italy)

^e MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

Dementia; Frontotemporal lobar degeneration; Tau; Tauopathy; White matter

Indexed keywords

MYELIN; TAU PROTEIN; FORMALDEHYDE; PARAFFIN;

ADULT; AGED; AMYGDALOID NUCLEUS; ARTICLE; CELL INCLUSION; CLINICAL ARTICLE; DEGENERATIVE DISEASE; DISEASE SEVERITY; FEMALE; FRONTAL CORTEX; FRONTAL VARIANT FRONTOTEMPORAL DEMENTIA; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MALE; MICROGLIA; MOTONEURON; MOTOR NEURON DISEASE; NERVE FIBER; NEUROPATHOLOGY; OLIGODENDROGLIA; PRIORITY JOURNAL; REDUCTION; SHY DRAGER SYNDROME; SUBICULUM; SYMPTOM; TAUOPATHY; TEMPORAL CORTEX; WESTERN BLOTTING; WHITE MATTER; BRAIN; DEMENTIA; ELECTRON MICROSCOPY; GENETICS; GLIA; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; PATHOLOGY;

AGED; BRAIN; DEMENTIA; FEMALE; FORMALDEHYDE; HUMANS; IMMUNOHISTOCHEMISTRY; INCLUSION BODIES; MALE; MICROSCOPY, ELECTRON; MIDDLE AGED; NEUROGLIA; PARAFFIN EMBEDDING; TAU PROTEINS; TAUOPATHIES;

EID: 54449096081     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/NEN.0b013e318187a80f     Document Type: Article

References (53)

1. Cairns NJ, Bigio EH, Mackenzie IR, et al. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: Consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol 2007;114:5-22
2. Boxer AL, Miller BL. Clinical features of frontotemporal dementia. Alzheimer Dis Assoc Disord 2005;19(suppl 1):S3-S6
3. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria. Neurology 1998; 51:1546-1554
4. Knibb JA, Kipps CM, Hodges JR. Frontotemporal dementia. Curr Opin Neurol 2006;19:565-571
5. Goedert M, Spillantini MG. A century of Alzheimer's disease. Science 2006;314:777-781
6. Neumann M, Sampathu DM, Kwong LK, et al. Ubiquitinated TDP-43 in frontotemporal degeneration and amyotrophic lateral sclerosis. Science 2006;314:130-133
7. Arai T, Hasegawa M, Akiyama H, et al. TDP-43 is a component of ubiquitin-positive, tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 2006;351:602-611
8. Poorkaj P, Bird TD, Wijsman E, et al. Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann Neurol 1998;43:815-825
9. Hutton M, Lendon CL, Rizzu P, et al. Association of missense and 5"-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998;393:702-705
10. Spillantini MG, Murrell JR, Goedert M, et al. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc Natl Acad Sci U S A 1998;95:7737-7741
11. Watts GDJ, Wymer J, Kovach MJ, et al. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet 2004;36:377-381
12. Skibinski G, Parkinson NJ, Brown JM, et al. Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Nat Genet 2005;37:806-808
13. Baker M, Mackenzie IR, Pickering-Brown SM, et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 2006;442:916-919 (Pubitemid 44285946)
14. Cruts M, Gijselinck I, van der Zee J, et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17. Nature 2006;442:920-924 (Pubitemid 44285947)
15. Sreedharan J, Blair IP, Tripathi VB, et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 2008;319:1668-1672
16. Gitcho MA, Baloh RH, Chakraverty S, et al. TDP-43 A315T mutation in familial motor neuron disease. Ann Neurol 2008;63:535-538
17. Kabashi E, Valdmanis PN, Dion P, et al. TARDP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet 2008;40:572-574
18. Lee VM-Y, Goedert M, Trojanowski JQ. Neurodegenerative tauopathies. Annu Rev Neurosci 2001;24:1121-1159
19. Conrad C, Andreadis A, Trojanowski JQ, et al. Genetic evidence for the involvement of tau in progressive supranuclear palsy. Ann Neurol 1997; 41:277-281
20. Dickson DW, Rademakers R, Hutton ML. Progressive supranuclear palsy: Pathology and genetics. Brain Pathol 2007;17:74-82
21. Bigio EH, Lipton AM, Yen SH, et al. Frontal lobe dementia with novel tauopathy: Sporadic multiple system tauopathy with dementia. J Neuropathol Exp Neurol 2001;60:328-341
22. Berry RW, Quinn B, Johnson N, et al. Pathological glial tau accumulations in neurodegenerative disease: Review and case report. Neurochem Int 2001;39:469-479
23. Ohara S, Tsuyuzaki J, Oide T, et al. A clinical and neuropathological study of an unusual case of sporadic tauopathy. A variant of corticobasal degeneration? Neurosci Lett 2002;330:84-88
24. Powers JM, Byrne NP, Ito M, et al. A novel leukoencephalopathy associated with tau deposits primarily in white matter glia. Acta Neuropathol 2003;106:181-187
25. Ferrer I, Hernandez I, Boada M, et al. Primary progressive aphasia as the initial manifestation of corticobasal degeneration and unusual tauopathies. Acta Neuropathol 2003;106:419-435
26. Tan CF, Piao YS, Kakita A, et al. Frontotemporal dementia with co-occurrence of astrocytic plaques and tufted astrocytes, and severe degeneration of the cerebral white matter: A variant of corticobasal degeneration? Acta Neuropathol 2005;109:329-338
27. Piao YS, Tan CF, Iwanaga K, et al. Sporadic four-repeat tauopathy with frontotemporal degeneration, parkinsonism and motor neuron disease. Acta Neuropathol 2005;110:600-609
28. Sakai K, Piao YS, Kikugawa K, et al. Corticobasal degeneration with focal, massive tau accumulation in the subcortical white matter astrocytes. Acta Neuropathol 2006;112:341-348
29. Murrell J, Farlow M, Ghetti B, et al. A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science 1991;254:97-99
30. Baker M, Litvan I, Houlden H, et al. Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum Mol Genet 1999;8:711-715 (Pubitemid 29139987)
31. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990;31: 545-548
32. Goedert M, Spillantini MG, Cairns NJ, et al. Tau proteins of Alzheimer paired helical filaments: Abnormal phosphorylation of all six brain isoforms. Neuron 1992;8:159-168
33. Crowther RA. Straight and paired helical filaments in Alzheimer disease have a common structural unit. Proc Natl Acad Sci U S A 1991;88:2288-2292
34. Braak H, Alafuzoff I, Arzberger T, et al. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 2006;112:389-404
35. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-486
36. Dickson DW, ed. Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders. Basel, Switzerland: ISN Neuropath Press, 2003
37. de Silva R, Lashley T, Strand C, et al. An immunohistochemical study of cases of sporadic and inherited frontotemporal lobar degeneration using 3R- and 4R-specific tau monoclonal antibodies. Acta Neuropathol 2006; 111:329-340
38. Ikeda K, Akiyama H, Arai T, et al. Pick-body-like inclusions in corticobasal degeneration differ from Pick bodies in Pick's disease. Acta Neuropathol 2002;103:115-118
39. Giaccone G, Marcon G, Mangieri M, et al. Atypical tauopathy with massive involvement of the white matter. Neuropathol Appl Neurobiol 2008;34:468-472
40. Yamazaki M, Hasegawa M, Mori O, et al. Tau-positive fine granules in the cerebral white matter: A novel finding among the tauopathies exclusive to parkinsonism-dementia complex of Guam. J Neuropathol Exp Neurol 2005;64:839-846
41. Yamada T, McGeer PL. Oligodendroglial microtubular masses: An abnormality observed in some human neurodegenerative diseases. Neurosci Lett 1990;120:163-166
42. Crowther RA, Goedert M. Abnormal tau-containing filaments in neurodegenerative diseases. J Struct Biol 2000;130:271-279
43. Molina JA, Probst A, Villanueva C, et al. Primary progressive aphasia with glial cytoplasmic inclusions. Eur Neurol 1998;40:71-77
44. Josephs KA, Katsuse O, Beccano-Kelly DA, et al. Atypical progressive supranuclear palsy with corticospinal tract degeneration. J Neuropathol Exp Neurol 2006;65:396-405
45. Liu WK, Le TV, Adamson J, et al. Relationship of the extended tau haplotype to tau biochemistry and neuropathology in progressive supranuclear palsy. Ann Neurol 2001;50:494-502
46. Papp MI, Kahn JE, Lantos PL. Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy, and Shy-Drager syndrome). J Neurol Sci 1989;94:79-100
47. Lantos PL. The definition of multiple system atrophy: A review of recent developments. J Neuropath Exp Neurol 1998;57:1099-1111
48. Konagaya M, Konagaya Y, Sakai M, et al. Progressive cerebral atrophy in multiple system atrophy. J Neurol Sci 2002;195:123-127
49. Shibuya K, Nagatomo H, Iwabuchi K, et al. Asymmetrical temporal lobe atrophy with massive neuronal inclusions in multiple system atrophy. J Neurol Sci 2000;179:50-58
50. Konagaya M, Sakai M, Matsuoka Y, et al. Multiple system atrophy with remarkable frontal lobe atrophy. Acta Neuropathol 1999;97:423-428
51. Spillantini MG, Crowther RA, Jakes R, et al. Filamentous αsynuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. Neurosci Lett 1998;251:205-208 (Pubitemid 28381082)
52. Goedert M. Alpha-synuclein and neurodegenerative diseases. Nat Rev Neurosci 2001;2:492-501
53. Wenning GK, Quinn N, Magalhaes M, et al. "Minimal change" multiple system atrophy. Mov Disord 1994;9:161-166